Cementless total hip arthroplasty for the management of tuberculosis coxitis

Yusuf Oztürkmen1, Mahmut Karamehmetoğlu, Cem Leblebici

  • 12nd Department of Orthopaedic Surgery and Traumatology, Istanbul Education and Research Hospital, Org. Abdurrahman Nafiz Gürman Cad. Samatya - Fatih, Kocamustafapaşa, 34098 Istanbul, Turkey. yozturkmen@yahoo.com

Insights

Cementless total hip arthroplasty (THA) effectively treats hip tuberculosis, improving function and relieving pain. Combining surgery with a year of antituberculous medication prevents infection recurrence.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Rheumatology

Background:

  • Hip tuberculosis is a debilitating condition requiring effective treatment for bone destruction.
  • Evaluating diagnostic methods and clinical outcomes is crucial for managing hip tuberculosis.

Purpose of the Study:

  • To assess the efficacy of cementless total hip arthroplasty (THA) in treating hip tuberculosis.
  • To determine if THA is a viable option for patients with current or past hip tuberculosis infections.

Main Methods:

  • Retrospective analysis of nine patients with active hip tuberculosis treated with cementless THA.
  • Preoperative diagnosis confirmed by open biopsy, histopathology, and imaging (radiographs, MRI).
  • Surgical resection of infected tissue followed by cementless THA and 1-year postoperative antituberculous medication.

Main Results:

  • Significant improvement in Harris Hip Score (mean 94.8) post-THA.
  • Normalization of inflammatory markers (ESR, C-reactive protein) within 3-4 months.
  • No tuberculosis reactivation observed during an average 5.6-year follow-up; stable implants with bone ingrowth.

Conclusions:

  • Cementless THA is a safe and effective treatment for advanced hip tuberculosis, offering symptomatic relief and functional gains.
  • Thorough surgical debridement and prolonged postoperative antituberculous chemotherapy are essential to prevent disease recurrence.
Abstract

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories: